E. Martino et al., ENHANCED SUSCEPTIBILITY TO AMIODARONE-INDUCED HYPOTHYROIDISM IN PATIENTS WITH THYROID AUTOIMMUNE-DISEASE, Archives of internal medicine, 154(23), 1994, pp. 2722-2726
Background: The iodine-rich antiarrhythmic drug, amiodarone, can induc
e both thyrotoxicosis and hypothyroidism, the former being more freque
nt in iodine-deficient areas, the latter in iodine-sufficient areas. I
n this study we evaluated prospectively thyroid function in amiodarone
-treated patients with positive or negative baseline thyroid autoantib
ody test results who resided in a moderately iodine-deficient area of
Italy. Subjects: Two groups of patients received long-term amiodarone
treatment: Group 1 included 13 patients with negative thyroid autoanti
body test results. Group 2 consisted of seven patients with positive t
hyroid autoantibody test results and thyroid ultrasound patterns compa
tible with Hashimoto's thyroiditis. The control group (group 3) includ
ed 16 untreated euthyroid patients with Hashimoto's thyroiditis. All s
ubjects resided in a mildly iodine-deficient area of Italy (Southern S
ardinia) and had low urinary iodine values. Patients in groups 1 and 2
had markedly elevated urinary iodine excretion during treatment. The
follow-up period ranged from 6 to 29 months in group 1, from 4 to 9 mo
nths in group 2, and from 12 to 55 months in group 3. Results: Two (15
%) of 13 patients in group 1 with nodular goiter developed thyrotoxico
sis. No patient in this group developed circulating thyroid autoantibo
dies. Five (71%) of seven patients in group 2 became hypothyroid after
4 to 9 months of amiodarone treatment associated with a rise in serum
thyroid autoantibody levels. No patient in group 3 became hypothyroid
. Conclusions: (1) Amiodarone administration can cause both thyrotoxic
osis and hypothyroidism (2) Hypothyroidism is far more frequent in pat
ients with preexisting thyroid autoimmune disease. (3) Amiodarone can
modify the natural history of Hashimoto's thyroiditis. (4) Circulating
thyroid autoantibodies do not appear in amiodarone-treated patients w
ho have negative test results prior to therapy.